Biomarker Research for Personalized Medicine
Conditions
Hematologic Neoplasms
Conditions: official terms
Hematologic Neoplasms
Study Type
Observational
Study Phase
N/A
Study Design
Time Perspective: Prospective
Overall Status
Recruiting
Summary
The aim of this study :

1. Through the study of genes of protein, transporter, translator and epigenome investigating the effect of anti-cancer treatment or the key factor of the MDR (Multidrug resistance) on the blood cancer patients who are under the anti-cancer sork treatment

2. Giving a service of anticancer medicine therapeutic drug monitoring (TDM) and genotyping
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: N/A
Gender: Both
Criteria: Inclusion Criteria:

- Korean

- Clinical diagnosis of Hematologic neoplasms
Location
Inje University
Busan, Korea, Republic of
Status: Recruiting
Contact: Jae Gook Shin, M.D., Ph.D. - 82-51-890-6709 - phshinjg@inje.ac.kr
Start Date
April 2009
Sponsors
Inje University
Source
Inje University
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page